Cargando…
Investigation of the mechanisms of action behind Electromotive Drug Administration (EMDA)
OBJECTIVE: Bladder cancer is a cause of considerable morbidity worldwide. Electromotive Drug Administration is a method that combines intravesical chemotherapy with local electric field application. Electroporation has been suggested among other mechanisms as having a possible role in the therapy, s...
Autores principales: | Kos, Bor, Vásquez, Juan Luis, Miklavčič, Damijan, Hermann, Gregers G.G., Gehl, Julie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012313/ https://www.ncbi.nlm.nih.gov/pubmed/27635313 http://dx.doi.org/10.7717/peerj.2309 |
Ejemplares similares
-
Office bladder distention with Electromotive Drug Administration (EMDA) is equivalent to distention under General Anesthesia (GA)
por: Rose, Amy E, et al.
Publicado: (2005) -
Conservative treatment for high-risk NMIBC failing BCG treatment: who benefits from adding electromotive drug administration (EMDA) of mitomycin C (MMC) to a second BCG induction cycle?
por: Busetto, Gian Maria, et al.
Publicado: (2023) -
Applications of electromotive drug administration in urology
por: Hashemi, Safiya, et al.
Publicado: (2020) -
ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk “BCG failure” non muscle invasive bladder cancer: 3 years follow-up outcomes
por: Racioppi, Marco, et al.
Publicado: (2018) -
Effect of Blood Vessel Segmentation on the Outcome of Electroporation-Based Treatments of Liver Tumors
por: Marčan, Marija, et al.
Publicado: (2015)